O besity afflicts a growing proportion of the US population 1 and has been reported to have a negative impact on surgical outcomes across specialties. [2] [3] [4] [5] In the field of spine surgery, numerous studies have examined the impact of obesity on complications, cost, and outcomes in thoracolumbar surgery [6] [7] [8] [9] [10] ; however, to our knowledge, no study has investigated the direct impact of obesity on patient-reported outcomes (PROs) of anterior surgery in the cervical spine. The association of obesity with PROs following anterior cervical discectomy and fusion (ACDF) has not been established.
There are a few recent studies that have investigated the impact of obesity on complications and cost following cervical surgery. Buerba et al 11 reported no increased risk of 30-day complications in those with a high body mass index (BMI) undergoing cervical fusions. Minhas et al 12 also reported that obesity was an independent predictor of increased cost following anterior cervical fusions. Although these studies provided useful information, each was a short-term study using administrative databases, and neither reported the impact of obesity on PROs. With the growing emphasis on PROs and satisfaction driving reimbursement, [13] [14] [15] it is important to consider the impact of obesity on these measures.
The purpose of the current study was to investigate the effect of obesity on PROs following ACDF. We hypothesized that obese patients would have worse PRO scores at 12 months following surgery compared with nonobese patients. We further hypothesized that there would be no difference in the degree of a clinically important difference between obese and nonobese patients undergoing ACDF.
METHODS Patients
We used a longitudinal registry database to analyze consecutive patients undergoing elective ACDF for symptomatic disc herniation, stenosis, or spondylolisthesis from October 2010 to November 2014 at a single academic institution. Inclusion criteria were age 18 years or older, failure of 3 months of conservative care or progressive neurological deficit, history and physical exam with correlative imaging, and a minimum follow-up of 12 months with complete outcomes data. Exclusion criteria were cases of trauma, tumor, infection, urgent/ emergent surgery, and deformity and patients initially presenting with pseudarthrosis from a previous procedure. Institutional review board approval was obtained. 
PRO Measures
PROs were collected in person or by telephone interview at baseline and at 3 and 12 months postoperatively. Patients were defined as "obese" with a BMI $35, based on the World Health Organization definition of class II obesity. 16 The Neck Disability Index (NDI), Short-Form 12 (SF-12) physical and mental component scales (PCS and MCS), EuroQol-5D (EQ-5D), Numerical Rating Scale (NRS) for pain, and modified Japanese Orthopaedic Association (mJOA) scale score were used. Each of these PRO measurement tools is validated and widely used in the spine literature.
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Statistical Analysis
Descriptive statistics were used to examine mean scores, SDs, and frequency of demographic and clinical characteristics of the study population. x 2 tests and Student t tests assessed the association of obesity with PRO measures, as well as the percentage of patients achieving a minimal clinically important difference (MCID) for NDI and satisfaction at 12 months. The MCID for NDI was set at 17.3%, which is specific to ACDF as established by Parker et al. 28 Multivariable linear regression models were built for each PRO measure: disability (NDI), quality of life (EQ-5D), pain (NRS for neck pain and arm pain), general health (SF-12 MCS and PCS), and mJOA scale score. Baseline variables including age, sex, smoking status, baseline PROs, American Society of Anesthesiologists grade, diabetes, hypertension, depression and anxiety, number of levels involved, duration of symptoms, and BMI were included to determine the impact of BMI on PROs 12 months after surgery. A subgroup analysis was also performed, dividing patients into BMIs ,25, 25 to 29.9, 30 to 34.9, 35 to 39.9, and $40. P , .05 was considered statistically significant. Statistical analysis was performed using SPSS version 22 (IBM, Armonk, New York).
Power Analysis
Preliminary data showed that the 12-month postsurgery NDI was 25 6 17.5 (mean 6 SD). Assuming that the mean NDI at 12 months in the nonobese and obese groups is 20 6 17.5 and 26 6 17.5, respectively, and using a sampling ratio of 2, a sample size of 79 patients in the obese group and 158 patients in the nonobese group would give us 80% power to detect a significant difference of 6 points in 12-month NDI between the 2 groups, with a type I error rate of 0.05 based on a 1-sided, 2-sample t test. With 79 obese patients and 158 nonobese patients, we would be able to detect a significant difference of 0.15 in EQ-5D improvement (assuming a significant difference of 0.3), 0.9 in NRS neck and arm pain (assuming a significant difference of 2), 1.0 in mJOA scale score (assuming a significant difference of 3.2), and 5 points in SF-12 PCS and MCS (assuming a significant difference of 12.8), with 88% (EQ-5D), 95% (neck/arm pain), 73% (mJOA scale score), and 88% (SF-12) power, respectively. We would also be able to detect a difference of 0.15 (0.60 vs 0.75) in the percentage of patients satisfied with surgery, with 76% power and a difference of 0.15 (0.50 vs 0.65) in the percentage of patients achieving a clinically important difference for the NDI with 73% power.
RESULTS
Registry data were available for 777 patients undergoing elective cervical procedures during the study period. Of these, 299 patients undergoing ACDF met the inclusion criteria and were therefore analyzed (Table 1) . There were 80 patients (27%) with a BMI $35. The obese patients had significantly greater comorbidities, including diabetes (39% vs 22%, P = .03), hypertension (54% vs SIELATYCKI ET AL 43%, P = .002), and a higher rate of American Society of Anesthesiologists grade greater than 2 (79% vs 48%, P , .001). All PROs improved significantly over the course of 12 months in both BMI groups (Table 2 ). At baseline, obese patients (BMI $35) had worse myelopathy symptoms (mJOA scale score), worse general mental and physical health (SF-12 MCS and PCS score), and worse NRS arm pain scores compared with nonobese patients. There was no difference in baseline neck-related disability (NDI) between the 2 groups. At 12 months after surgery, there were no significant differences in the PROs between the obese and nonobese groups (Table 3) . There was no difference in the pre-to postoperative change scores in any of the PROs between the groups (Table 3 ). In addition, there was no difference in the percentage of patients achieving satisfaction (85% vs 85%, P = .80) or the MCID in the NDI (10.2 vs 10.4, P = .92) ( Table 3) .
On multivariate analysis after adjusting for baseline patient characteristics (age, sex, smoking status, baseline PROs, American Society of Anesthesiologists grades, and comorbidities including diabetes, hypertension, depression and anxiety, number of levels, and duration of symptoms), the preoperative BMI was not a predictor of less improvement in postoperative disability (NDI), quality of life (EQ-5D), neck and leg pain (NRS), general mental and physical health (SF-12 MCS and PCS), and mJOA scale scores 12 months after surgery. On subgroup analysis with patients separated into the World Health Organization BMI categories, there was no difference in PRO change scores across each World Health Organization BMI category (Table 4) . Copyright © Congress of Neurological Surgeons. Unauthorized reproduction of this article is prohibited.
DISCUSSION
In this study, we used longitudinal registry outcome data to investigate the association between obesity and patient-reported outcomes following elective ACDF for degenerative conditions. A BMI of $35 was associated with worse absolute scores in neckrelated disability and general health scores at baseline and at 12 months; however, there was no difference detected in pre-to postoperative change scores between BMI groups. Significantly, there was no difference detected in the percentage of patients achieving an MCID on the NDI and satisfaction 1 year after surgery. This study was powered to detect a 6-point difference in the NDI, a 0.15-point difference in the EQ-5D, a 0.9-point difference in the NRS for neck and arm pain, a 1-point difference in the mJOA scale score, and a 5-point difference in SF-12 PCS and MCS. As shown in Table 2 , the postoperative differences between obese and nonobese patients in each of these PROs were less than the changes that this study was powered to detect. Therefore, because no difference was found, we conclude that any difference that may actually exist would be less than what this study was powered to detect. These findings suggest that obese patients may achieve equally meaningful improvement in PROs and satisfaction compared with nonobese patients following ACDF. To our knowledge, this the first study to investigate the impact of obesity on PROs following ACDF. Most studies investigating the association between obesity and outcomes in spine surgery have focused on lumbar procedures, and there have been few to evaluate the impact of obesity in cervical surgery. Buerba et al 11 used the American College of Surgeons National Surgical Quality Improvement Program administrative database to evaluate the impact of obesity on 30-day complications following cervical fusions and found no association; however, long-term outcomes were not assessed and PROs were not included for analysis. Minhas et al 12 showed that age, diabetes, and obesity were predictors of increased cost for ACDF, but did not assess the impact of obesity on PROs. Riew et al 30 performed a useful study showing that work status, sensory function, litigation involvement, and higher disability scores were all predictors of outcomes following ACDF. In this study, they used the NDI, SF-36, and return to work, although obesity was one of the exclusion criteria and was therefore not assessed. 29 Other studies include obesity as a risk factor for airway compromise from swelling following ACDF. 30 The prevalence of obesity is increasing, and thus it is important to understand the impact of this comorbidity on patient-reported outcomes in cervical surgery both for patient counseling and surgical decision making. In this study, we have shown that although obese patients may have lower absolute scores on validated PROs, they can still achieve an equally meaningful clinical improvement following ACDF. Our findings support the hypothesis that obesity is not associated with a diminished treatment effect following ACDF.
Limitations
Our study is not without limitations. Patient-reported outcomes were obtained at baseline and at 12 months; longer term follow-up is therefore needed to assess the impact that obesity may have on durability. Nevertheless, studies have demonstrated that most patients undergoing spine surgery achieve maximal clinical improvement by 3 to 6 months; thus, the benefit of surgery is likely realized at the 12-month follow-up. 31 This study also does not evaluate the potential increased cost associated with obesity, which could increase the cost-to-benefit ratio. Additional work is under way to evaluate the impact of obesity on cost in cervical surgery. The study was powered to detect a significant difference in the PROs between obese and nonobese groups. The study was underpowered to detect a significant difference in satisfaction and an MCID in the NDI at 12 months after surgery. Furthermore, we had 30 patients with morbid obesity (BMI .40); a higher number of patients in this group might be able to detect a significant difference in the 12-month PROs, if one exists. Certainly, further studies with larger numbers of obese patients are required to further validate our findings. Nonetheless, using prospectively collected data, we demonstrate that obese patients can achieve improvement in outcomes as much as nonobese patients.
CONCLUSION
ACDF surgery provided significant improvement in all PROs 12 months after surgery. The obese patients had as much improvement as nonobese patients across all PRO scores at 12 months after surgery. There was no difference between the groups in the proportion of patients satisfied with surgery and those who achieved a clinically important difference across all PROs. These findings support the hypothesis that obese patients may achieve meaningful improvement following ACDF for degenerative conditions. 
